Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2007
10/24/2007EP1847535A1 1-(piperidin-4-yl)-1h-indole derivative
10/24/2007EP1847532A1 Igf-1r inhibitor
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846428A1 Anti-inflammatory conjugates of macrolides and coumarins
10/24/2007EP1846400A2 Tricyclic delta-opioid modulators
10/24/2007EP1846399A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
10/24/2007EP1846394A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/24/2007EP1846388A1 Thiophene compounds for inflammation and immune-related uses
10/24/2007EP1846379A1 Antidiabetic bicyclic compounds
10/24/2007EP1845981A1 Synthesis of sodium narcistatin and related compounds
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007CN101061119A Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
10/24/2007CN101061114A Amide derivatives, their manufacture and use as pharmaceutical agents
10/24/2007CN101061113A 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101061096A Cycloalkyl keto piperidine tachykinin receptor antagonists
10/24/2007CN101061095A Cycloalkyl piperidine tachykinin receptor antagonists
10/24/2007CN101060842A Chemical compounds
10/24/2007CN101058573A 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
10/24/2007CN100344626C Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285554 Pyrazole derivative
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285548 Urea substituted benzothiazoles
10/18/2007WO2007118137A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007116960A1 Oxazolidinone derivative having carbocyclic ring
10/18/2007WO2007116866A1 Hetero compound
10/18/2007WO2007116313A2 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007WO2007116229A1 Heterocyclic gpcr agonists
10/18/2007WO2007115966A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007WO2007115410A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007092531A3 Compounds and compositions as protein kinase inhibitors
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2007064345A3 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
10/18/2007WO2006055964A3 Zolmitriptan crystal forms
10/18/2007US20070244333 Method for preparing prostaglandin derivative
10/18/2007US20070244329 for production of drugs for treating Alzheimer's Disease
10/18/2007US20070244159 including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), such as 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, used for the treatment of genetic disorders such as cystic fibrosis, emphysema, hemochromatosis and protein C deficiency
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244130 Compounds and Compositions as Ppar Modulators
10/18/2007US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
10/18/2007US20070244118 Cyclic Amide Derivative, and Its Production and Use
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070244116 c-MET MODULATORS AND METHOD OF USE
10/18/2007US20070244115 Amino-Halogen-Imidazopyridines as Proton Pump Inhibitors
10/18/2007US20070244114 Compounds and therapeutical use thereof
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070244112 Novel tetrahydropyridothiophenes
10/18/2007US20070244111 Pyrazolopyrimidines
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/18/2007US20070244094 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/18/2007US20070244092 Therapeutic Compounds
10/18/2007US20070244088 New Pyridine Analogues II
10/18/2007US20070244086 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
10/18/2007US20070243134 Receptor Selective Cannabimimetic Aminoalkylindoles
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007CA2652109A1 Compositions and methods for modulating gated ion channels
10/18/2007CA2648804A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007CA2648529A1 Quinazolines for pdk1 inhibition
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007CA2648303A1 5-[monocyclic(hetero)arylsubstituted-1,2,4-oxadliazol-3-yl]-(fused heteroaryl substituted) compounds and their use as s1p1 agonists
10/18/2007CA2648168A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007CA2647448A1 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007CA2646676A1 Heterocyclic gpcr agonists
10/17/2007EP1845097A1 Oxadiazole derivatives as COMT inhibitors
10/17/2007EP1845096A1 12-Aza-epothilones, process for their preparation and their use as antiproliferative agents
10/17/2007EP1845090A1 Amide compound and thrombopoietin receptor activator
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844775A1 Therapeutic agent for herpes progenitalis
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1844042A1 Indole derivatives for treating viral infections
10/17/2007EP1844041A1 An improved process for the preparation of mycophenolate mofetil
10/17/2007EP1844011A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists
10/17/2007EP1843820A1 Multicyclic bis-amide mmp inhibitors
10/17/2007EP1843766A1 Antidiabetic bicyclic compounds
10/17/2007EP1648871B1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007EP1313717B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
10/17/2007CN101056874A Cyanine compound, optical recording material utilizing the compound, and optical recording medium
10/17/2007CN101056866A 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
10/17/2007CN101056639A 噻唑并吡啶激酶抑制剂 Thiazolopyridine kinase inhibitors
10/17/2007CN101054374A Flouroquinolone-oxazolidone derivative, composition, preparation method and application thereof
10/17/2007CN101054331A Racemization method for asymmetry optical activity 2-heterocycle substituted dihydropyrimidines compound
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/17/2007CN100343250C Indolyl derivatives
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/16/2007US7282594 Indole is treated with an aldehyde in the presence of a Lewis acid and a silicon hydride reducing agent, alkylating the C-3 position of indoles that contain acid-sensitive substituents at the N-1 position
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 647